Regulatory BCL2 promoter polymorphism (−938C>A) is associated with adverse outcome in patients with prostate carcinoma-Reference-Cited by-同舟云学术

Regulatory BCL2 promoter polymorphism (−938C>A) is associated with adverse outcome in patients with prostate carcinoma

Published:2011-03-25 Issue:10 Volume:129 Page:2390-2399
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bachmann Hagen S.,Heukamp Lukas C.,Schmitz Klaus J.,Hilburn Caroline F.,Kahl Philip,Buettner Reinhard,Nückel Holger,Eisenhardt Andreas,Rübben Herbert,Schmid Kurt Werner,Siffert Winfried,Eggert Angelika,Schramm Alexander,Schulte Johannes H.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. A history of prostate cancer treatment;Denmeade;Nat Rev Cancer,2002

2. International trends and patterns of prostate cancer incidence and mortality;Hsing;Int J Cancer,2000

3. Prostate cancer screening (United States);Waterbor;Cancer Causes Control,1995

4. Clinical practice. Localized prostate cancer;Walsh;N Engl J Med,2007

5. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging;Gleason;J Urol,1974

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (Bcl-2/Bax) and Proinflammatory Cytokine (TNF-α/IL-8) Genes on the Susceptibility and Progression of Myeloproliferative Neoplasms: A Case-Control Biomarker Study;Current Issues in Molecular Biology;2023-05-02

2. Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA;Arthritis Research & Therapy;2023-03-07

3. Antiapoptotic Gene Genotype and Allele Variations and the Risk of Lymphoma;Cancers;2023-02-05

4. Nanoinformatics and Personalized Medicine: An Advanced Cumulative Approach for Cancer Management;Current Medicinal Chemistry;2023-01

5. AnMGMTAllelic Variant Can Affect Biochemical Relapse in Prostate Cancer Patients;Anticancer Research;2022-12-30